We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Mitophagy and reactive oxygen species interplay in Parkinson's disease.
- Authors
Xiao, Bin; Kuruvilla, Joshua; Tan, Eng-King
- Abstract
Mitophagy impairment and oxidative stress are cardinal pathological hallmarks in Parkinson's disease (PD), a common age-related neurodegenerative condition. The specific interactions between mitophagy and reactive oxygen species (ROS) have attracted considerable attention even though their exact interplay in PD has not been fully elucidated. We highlight the interactions between ROS and mitophagy, with a focus on the signalling pathways downstream to ROS that triggers mitophagy and draw attention to potential therapeutic compounds that target these pathways in both experimental and clinical models. Identifying a combination of ROS inhibitors and mitophagy activators to provide a physiologic balance in this complex signalling pathways may lead to a more optimal outcome. Deciphering the exact temporal relationship between mitophagy and oxidative stress and their triggers early in the course of neurodegeneration can unravel mechanistic clues that potentially lead to the development of compounds for clinical drug trials focusing on prodromic PD or at-risk individuals.
- Subjects
PARKINSON'S disease; REACTIVE oxygen species; CLINICAL drug trials; CELLULAR signal transduction; DOSAGE forms of drugs
- Publication
NPJ Parkinson's Disease, 2022, Vol 8, Issue 1, p1
- ISSN
2373-8057
- Publication type
Article
- DOI
10.1038/s41531-022-00402-y